As of Jan 17
| +0.019 / +2.21%|
The 4 analysts offering 12-month price forecasts for Genesis Healthcare Inc have a median target of 2.13, with a high estimate of 7.00 and a low estimate of 1.00. The median estimate represents a +141.75% increase from the last price of 0.88.
The current consensus among 4 polled investment analysts is to Hold stock in Genesis Healthcare Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.